Eisai Co Ltd (EII) Stock Price & News

Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia

About Eisai Co Ltd

CEOHaruo Naito | Haruo Naito

Employees10.5K

FoundedDec 6, 1941

HeadquartersBunkyo City, Tokyo, Japan

SectorHealth Care

IndustryPharmaceutical industry

Websiteeisai.co.jp

All values in JPY	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	219.94B	205.43B	234.33B	235.63B
Cost of goods sold	51.08B	52.02B	51.09B	53.48B
Cost of revenue	51.08B	52.02B	51.09B	53.48B
Research and development expenses	39.20B	43.94B	43.71B	44.42B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	111.72B	108.23B	114.83B	120.40B
Operating expense	148.82B	163.92B	158.51B	165.45B
Total operating expenses	199.90B	215.94B	209.60B	218.93B
Operating income	20.03B	-10.51B	24.73B	16.70B
Other non operating income	-1.00M	-66.00M	-2.00M	2.00M
EBT including unusual items	22.00B	-7.94B	25.28B	16.35B
EBT excluding unusual items	22.00B	-10.55B	25.28B	16.35B
Income tax expense	4.16B	-4.75B	6.13B	4.23B
Effective tax rate	18.90%	59.77%	24.25%	25.88%
Other operating expenses	-2.10B	250.00M	-28.00M	624.00M
Net income	17.18B	-3.25B	18.24B	11.69B
Net profit margin	7.81%	-1.58%	7.78%	4.96%
Earnings per share	-	-	-	-
Interest and investment income	3.40B	462.00M	2.51B	1.82B
Interest expense	-1.43B	-439.00M	-1.96B	-2.18B
Net interest expenses	1.97B	23.00M	556.00M	-352.00M
Depreciation and amortization charges	-	11.51B	-	-
EBITDA	30.10B	-530.00M	34.15B	25.94B
Gain or loss from assets sale	-	1.40B	-	-

Ask anything